SBIR/STTR Research Award
Circulating Prostate Cancer Progenitor Cell Assay Development
Award amount
$747,553Program and phase
STTR · Phase IIAward year
2011Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- ANDROBIOSYS, INC.
- Proposal award date
- 2010-08-04
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- 2008.A
- Topic code
- A08-T041
Research abstract
The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Novel Biomarkers Assessment in the Progression from Androgen Dependent Prostate Cancer to Androgen Independent Prostate Cancer
- Circulating Prostate Cancer Progenitor Cell Assay Development